« Back to slide 1
Continue to slide 3 »

#9. Edwards Lifesciences Corp (EW) — $10K BECAME $44,766.66

Company Name:  Edwards Lifesciences Corp
Sector:  Medical Instruments & Supplies
Growth of $10,000.00
Without Dividends Reinvested Into EW

Edwards Lifesciences is engaged in medical treatments for structural heart disease and critical care monitoring. Co. manufactures heart valve systems and repairs products used to replace or repair a patient's diseased or defective heart valve. Co.'s technologies is focused on the less invasive repair or replacement of the mitral and tricuspid valves of the heart. Co. is also engaged in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. Co.'s products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Surgical Structural Heart, Critical Care, and Transcatheter Mitral and Tricuspid Therapies.

« Back to slide 1
Continue to slide 3 »
Start date: 08/19/2014
End date: 08/19/2019
Start price/share: $48.99
End price/share: $222.50
Dividends collected/share: $0.00
Total return: 354.17%
Average Annual Total Return: 35.32%
Starting investment: $10,000.00
Ending investment: $45,411.92
Years: 5.00

Presented with the assumption of reinvestment of any dividends on ex-date; historical stock values are shown adjusted for any subsequent splits.
Wise & Famous Investing Quotes
20 Largest Companies In The USA
20 Growth Stocks For 2020
10 Dividend Leaders Ready To Run
Best 5-Year Total Return Stocks
Best 10-Year Total Return Stocks
Best 2-Decade Total Return Stocks
Quotes delayed 20 minutes
Get Free SEC filing alerts for EW:
EW SEC Filing Email Alerts ServiceExternal link
 

Best 5 Year Total Return Stocks - Page 2 | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video.